Clinical Trials Directory

Trials / Completed

CompletedNCT04218604

The Ablate-by-LAW Study

Feasibility and Efficacy of Tailoring Ablation Index to Left Atrial Wall Thickness During Atrial Fibrillation Ablation: The Ablate By-LAW Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
106 (actual)
Sponsor
Centro Medico Teknon · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Of all the determinants of lesion creation during atrial fibrillation (AF) ablation, left atrial wall thickness (LAWT), as measured with multi-detector cardiac tomography (MDCT) is one key element that has been evaluated in some retrospective analyses but is not yet used per protocol to modulate the radiofrequency delivery. Adapting ablation index (AI) to LAWT would be very useful in standardising the ablation procedure with parameters fitted to every patient, enabling the development of a personalized approach that will both: i) increase efficacy by performing transmural lesions to prevent the formation of conduction gaps in the initial lesion set, and ii) increase safety by preventing excessive RF delivery on thin wall areas related to procedural complications, such as cardiac perforation or atrio-esophageal fistula. The investigators sought to evaluate the feasibility, safety, efficacy and reproducibility of guiding AF ablation procedures with the integrated MDCT-derived LAWT information.

Conditions

Interventions

TypeNameDescription
PROCEDUREPersonalized atrial fibrillation ablationAtrial fibrillation (AF) ablation adapting the ablation index (AI) target in a point-by-point manner, according the local left atrial wall thickness (LAWT), as measured by multidetector cardiac tomography (MDCT)

Timeline

Start date
2020-11-21
Primary completion
2022-07-20
Completion
2022-07-20
First posted
2020-01-06
Last updated
2023-08-30

Locations

5 sites across 3 countries: Germany, Italy, Spain

Source: ClinicalTrials.gov record NCT04218604. Inclusion in this directory is not an endorsement.